Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLOW
576
DELISTED
SPX FLOW, Inc.
FLOW
| $19.5M | 0.04% |
+567,751
| New | +$19.3M |
|
577
Royal Gold
RGLD
$22.3B
| $19.5M | 0.04% |
415,405
+405,004
| +3,894% | +$20.8M |
|
|
VGR
578
DELISTED
Vector Group Ltd.
VGR
| $19.5M | 0.04% |
1,476,684
+1,422,048
| +2,603% | +$19.2M |
|
579
Rithm Capital
RITM
$5.72B
| $19.4M | 0.04% |
1,483,885
-962,898
| -39% | -$14.2M |
|
|
GAP
580
The Gap Inc
GAP
$7.33B
| $19.3M | 0.04% |
678,601
+669,541
| +7,390% | +$23M |
|
581
FerroAtlántica
GSM
$757M
| $19.3M | 0.04% |
1,587,981
+462,824
| +41% | +$6.83M |
|
582
LKQ Corp
LKQ
$6.51B
| $19.2M | 0.04% |
678,204
+604,170
| +816% | +$18.4M |
|
583
Intuit
INTU
$101B
| $19.2M | 0.04% |
216,427
-1,088,703
| -83% | -$106M |
|
|
PEGI
584
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $19.2M | 0.04% |
1,005,622
-1,142,686
| -53% | -$27M |
|
|
AEGR
585
DELISTED
Aegerion Pharmaceuticals
AEGR
| $19.2M | 0.04% |
1,408,396
-94,047
| -6% | -$1.67M |
|
586
Interface
TILE
$2.21B
| $19.1M | 0.04% |
850,621
+334,781
| +65% | +$8.23M |
|
|
MNTA
587
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $19.1M | 0.04% |
1,162,414
+263,292
| +29% | +$5.39M |
|
|
TTM
588
DELISTED
Tata Motors Limited
TTM
| $19M | 0.04% |
844,548
+472,289
| +127% | +$13M |
|
589
IPG Photonics
IPGP
$3.01B
| $18.9M | 0.04% |
248,765
+87,450
| +54% | +$7.41M |
|
590
Extra Space Storage
EXR
$30.9B
| $18.8M | 0.04% |
243,690
-771,483
| -76% | -$56.5M |
|
|
TRVN
591
DELISTED
Trevena, Inc.
TRVN
| $18.8M | 0.04% |
2,907
+2,577
| +781% | +$12.7M |
|
|
TRAK
592
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $18.8M | 0.04% |
297,688
+140,659
| +90% | +$8.79M |
|
593
International Paper
IP
$21.7B
| $18.7M | 0.04% |
523,783
+309,353
| +144% | +$13.1M |
|
594
AtriCure
ATRC
$2.51B
| $18.7M | 0.04% |
854,769
+116,668
| +16% | +$2.92M |
|
|
HCBK
595
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $18.7M | 0.04% |
1,838,658
+826,813
| +82% | +$8.17M |
|
596
RenaissanceRe
RNR
$13.7B
| $18.6M | 0.04% |
175,214
-598,994
| -77% | -$62.9M |
|
597
KLA
KLAC
$237B
| $18.6M | 0.04% |
3,716,380
+2,114,170
| +132% | +$10.9M |
|
598
Royal Caribbean
RCL
$78.4B
| $18.6M | 0.04% |
208,390
+169,818
| +440% | +$14.9M |
|
599
Cameco
CCJ
$44.5B
| $18.5M | 0.04% |
1,521,661
+178,467
| +13% | +$2.41M |
|
|
DWA
600
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $18.5M | 0.04% |
1,059,550
-598,558
| -36% | -$12.9M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.